Skye Bioscience SKYE
NASDAQ SKYE
$1.61 +0.02 (+1.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Long-Term Debt Repayments (2013 - 2026)

Updated

Skye Bioscience (SKYE) recorded Long-Term Debt Repayments of $107,288 in Q2 2026, up 50.0% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Long-Term Debt Repayments (2013 - 2026) Analysis & Trends

On a TTM basis, Skye Bioscience's Long-Term Debt Repayments came in at $178,813 as of Jun 30, 2026, up 996.6% year-over-year; for FY2023, it was $259,335, down 5.9% from FY2022.

  • Across earlier years, Long-Term Debt Repayments came in at $275,537 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Skye Bioscience 7.07 Mn 7.07 Mn - 107,288.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,288.00
Mar 31, 2026 71,525.00
Oct 31, 2013 4,423.00
API Access

Skye Bioscience Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SKYE&period=max&api_key=YOUR_API_KEY